Press releases - 05 March 2024 10:00 CET
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FEBRUARY 2024
Zinzino group revenue increased with a total of 25 %, compared with the previous year.
The revenue in February for Zinzino's sales markets increased by 27 % and amounted to SEK 138.7 (109.6) million. Faun Pharma's external sales increased by 11 % and amounted to SEK 9.7 (8.7) million. Overall, the Group increased revenues by 25 % to SEK 148.4 (118.3) million compared with the previous year.
Accumulated revenue for January – February 2024 increased by 20 % to SEK 297.4 (247.8) million.
Revenues were distributed as follows:
| Regions,MSEK | 24-Feb | 23-Feb | Change | YTD 2024 | YTD 2023 | Change |
| The Nordics | 22.2 | 23.2 | -4% | 45.1 | 46.8 | -4% |
| Central Europe | 36.7 | 26.9 | 36% | 77.6 | 55.4 | 40% |
| East Europe | 29.9 | 25.2 | 19% | 61.7 | 58,0 | 6% |
| South & West Europe | 24.6 | 14.4 | 71% | 46.6 | 30.3 | 54% |
| The Baltics | 8.3 | 6.1 | 36% | 16.3 | 13.4 | 22% |
| North America | 12.2 | 6.3 | 94% | 22.5 | 12.6 | 79% |
| Asia-Pacific | 3.6 | 6.5 | -45% | 7.6 | 11.1 | -32% |
| Africa | 1.2 | 1,0 | 20% | 2.2 | 2.4 | -8% |
| Zinzino | 138.7 | 109.6 | 27% | 279.6 | 230.0 | 22% |
| Faun Pharma | 9.7 | 8.7 | 11% | 17.8 | 17.8 | 0% |
| Zinzino Group | 148.4 | 118.3 | 25% | 297.4 | 247.8 | 20% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge: marketing@zinzino.com
Certified Adviser: Carnegie Investment Bank AB (publ)
Share this page
Or copy link